CSPHF
Price
$1.00
Change
+$0.14 (+16.28%)
Updated
Sep 23 closing price
Capitalization
1.29B
Intraday Buy/Sell Signals
NBTX
Price
$26.57
Change
-$1.22 (-4.39%)
Updated
Oct 16 closing price
Capitalization
1.32B
32 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

CSPHF vs NBTX

Header iconCSPHF vs NBTX Comparison
Open Charts CSPHF vs NBTXBanner chart's image
CSTONE PHARMACEUTICALS
Price$1.00
Change+$0.14 (+16.28%)
Volume$150
Capitalization1.29B
Nanobiotix SA
Price$26.57
Change-$1.22 (-4.39%)
Volume$53.9K
Capitalization1.32B
CSPHF vs NBTX Comparison Chart in %
CSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSPHF vs. NBTX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Hold and NBTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (CSPHF: $1.00 vs. NBTX: $26.57)
Brand notoriety: CSPHF and NBTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 6% vs. NBTX: 67%
Market capitalization -- CSPHF: $1.29B vs. NBTX: $1.32B
CSPHF [@Biotechnology] is valued at $1.29B. NBTX’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileNBTX’s FA Score has 0 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • NBTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CSPHF and NBTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSPHF’s TA Score shows that 1 TA indicator(s) are bullish while NBTX’s TA Score has 3 bullish TA indicator(s).

  • CSPHF’s TA Score: 1 bullish, 1 bearish.
  • NBTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CSPHF is a better buy in the short-term than NBTX.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while NBTX (@Biotechnology) price change was -11.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.20%. For the same industry, the average monthly price growth was +16.20%, and the average quarterly price growth was +80.31%.

Reported Earning Dates

NBTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (-1.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBTX($1.32B) and CSPHF($1.29B) have the same market capitalization . NBTX YTD gains are higher at: 825.784 vs. CSPHF (343.459).
CSPHFNBTXCSPHF / NBTX
Capitalization1.29B1.32B98%
EBITDAN/AN/A-
Gain YTD343.459825.78442%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
CSPHFNBTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
40%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
36%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
35%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
35%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIDSX3.21N/A
N/A
Midas Discovery
EADIX18.91N/A
N/A
Eaton Vance Global Equity Income A
DIAMX29.44N/A
N/A
Diamond Hill Long-Short Inv
BIRDX8.54N/A
N/A
iShares Developed Real Estate Idx Instl
GFDDX108.13N/A
N/A
Invesco Global R5

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
BCAB - CSPHF
9%
Poorly correlated
-11.29%
SIGY - CSPHF
8%
Poorly correlated
N/A
NBTX - CSPHF
7%
Poorly correlated
-4.39%
HYFT - CSPHF
5%
Poorly correlated
-4.09%
More

NBTX and

Correlation & Price change

A.I.dvisor tells us that NBTX and PBYI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBTX
1D Price
Change %
NBTX100%
-4.39%
PBYI - NBTX
28%
Poorly correlated
-1.64%
GLMD - NBTX
26%
Poorly correlated
-3.42%
ADAP - NBTX
25%
Poorly correlated
+6.03%
VALN - NBTX
25%
Poorly correlated
-2.57%
CRMD - NBTX
25%
Poorly correlated
-5.00%
More